"Late last year, the US Food and Drug Administration (FDA) centre for veterinary medicine gave conditional approval for a drug created by San Francisco-based biotech company Loyal that could be available as a life-extending tool for large dogs by 2026."
"LOY-001 can successfully reduce IGF-1 levels in the blood in a week, according to Halioua."
[
Collection
]
[
|
...
]